STRENSIQ
NDC 25682-010, ASFOTASE ALFA, solution, from Alexion Pharmaceuticals, Inc..
- Product NDC
- 25682-010
- Status
- Listed
- Labeler
- Alexion Pharmaceuticals, Inc.
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125513
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/25682-010 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ASFOTASE ALFA18 mg/.45mL
Pharmacologic classes
Alkaline Phosphatase [CS]; Tissue-nonspecific Alkaline Phosphatase [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 25682-010-12 | 25682001012 | 12 VIAL in 1 CARTON (25682-010-12) / .45 mL in 1 VIAL (25682-010-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/3387574f-5eaa-4501-a71d-4cbfbd563031
Use it
Look up 25682-010 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/25682-010 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 25682-010. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.